Location permission needed for a better experience.
EN
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2019 EBU Diploma European Board of Urology Fellowship
  • 2018 Sağlık Bilimleri Üniversitesi İstanbul Eğitim Araştırma Hastanesi Üroloji
  • 2012 Ege Üniversitesi Tıp Fakültesi
EXPERIENCE
  • 2020 Acıbadem Sağlık Grubu
  • 2018 - 2020 Çukurca Devlet Hastanesi / Üroloji / Uzman Hekim
  • 2013 - 2018 Sağlık Bilimleri Üniversitesi / İstanbul Eğitim ve Araştırma Hastanesi / Üroloji Kliniği / Üroloji Asistan Hekim
  • 2012 - 2013 Bulanık Devlet Hastanesi / Acil Servis / Pratisyen Hekim
MEMBERSHIPS
  • Ürolojik Cerrahi Derneği
  • Endoüroloji Derneği
  • European Association of Urology (EAU)
  • Türk Üroonkoloji Derneği
  • Türk Üroloji Derneği
PUBLICATIONS
  • Evaluation of the Sexual Functioning of Individuals Living in Turkey During the COVID-19 Pandemic: An Internet-Based Nationwide Survey Study. Sex Med. 2021;9(1):100279. Karsiyakali N, Sahin Y, Ates HA, Okucu E, Karabay E.
  • Increased PI-RADS Scores in multiparametric Magnetic Resonance Imaging may Predict More Extensive Disease in Radical Prostatectomy Specimens. Bull Urooncol 2021;20(3):147-152. DOI: 10.4274/uob.galenos.2020.1874. Karşıyakalı N, Özgen MB, Özveren B, Akbal C, Dinçer A, Durak H, Türkeri L.
  • Key Steps in Retzius-Sparing Robot-Assisted Radical Prostatectomy with a Novel Technique for Suspension of Parietal Peritoneum. Videourology. 2021;35(2). https://doi.org/10.1089/vid.2020.0114. Karsiyakali N, Ozgen MB, Ozveren B, Turkeri L.
  • Suboptimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy. Urology. 2021 Feb;148:217-223. doi: 10.1016/j.urology.2020.08.031. Epub 2020 Aug 29. Karsiyakali N, Ozgen MB, Ozveren B, Akbal C, Dincer A, Durak H, Turkeri L.
  • Increased PI-RADS Scores in multiparametric Magnetic Resonance Imaging may Predict More Extensive Disease in Radical Prostatectomy Specimens. Bull Urooncol 2021;20(3):147-152. DOI: 10.4274/uob.galenos.2020.1874. Karşıyakalı N, Özgen MB, Özveren B, Akbal C, Dinçer A, Durak H, Türkeri L.
  • Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital. Actas Urol Esp. 2021;45(1):30-8. Sarikaya S, Karsiyakali N, Kaya E, Topuz B, Ebiloglu T, Zor M.
  • The prostatic adenocarcinoma with mucinous features: A review of the literature with three case reports. J Cancer Res Ther. 2021 Apr-Jun;17(2):596-598. doi: 10.4103/jcrt.JCRT_673_18. Karsiyakali N, Karabay E, Yucetas U, Koca SB, Akay AF, Kadihasanoglu M.
  • Identifying the predictors of estimated glomerular filtration rate after partial nephrectomy with a nonlinear regression model. Int J Clin Pract. 2021 Mar;75(3):e13763. doi: 10.1111/ijcp.13763. Epub 2020 Nov 3. Karabay E, Tosun C, Karsiyakali N, Kayar K, Aykan S, Aslan AR, Yucebas OE, Ozturk MI.
  • A Case of Eccrine Porocarcinoma Accompanying Renal Cell Carcinoma. Bull Urooncol 2021;20(3):186-188. DOI: 10.4274/uob.galenos.2020.1487. Mansur AT, Karşıyakalı N, Demirci GT, Köseoğlu H, Akman Y, Yıldız Ş.
  • Renal pelvis urine Gram stain as a traditional, but new marker in predicting postoperative fever and stone culture positivity in percutaneous nephrolithotomy: an observational, prospective, non-randomized cohort study. World J Urol. 2021 Jun;39(6):2135-2146. doi: 10.1007/s00345-020-03381-y. Epub 2020 Jul 28. Karsiyakali N, Yucetas U, Karatas A, Karabay E, Okucu E, Erkan E.
  • A Case of Unclassified Renal Cell Carcinoma (RCC) Initially Considered as Translocation RCC and Review of the Literature. Bull Urooncol 2021;20(2):122-125. DOI: 10.4274/uob.galenos.2020.1742. Karşıyakalı N, Özgen MB, Özveren B, Ekici ID, Türkeri L.
  • Evaluation of sexual functions in female rosacea patients: a prospective, case-control study. Int J Impot Res. 2020 Nov;32(6):628-634. doi: 10.1038/s41443-020-0275-z. Epub 2020 Apr 14. Aktas Karabay E, Karsiyakali N, Karabay E.
  • Comparison of the effectiveness of Shock Wave Lithotripsy and Retrograde Intrarenal Surgery in Treatment of Lower Pole Kidney Stones: Single Center Case-Control Study. Yeni Üroloji Dergisi. 2020; 15(2): 127-134. Yalçın S, Karşıyakalı N, Kaya E, Yılmaz S, Gazel E, Asgarlı S, Gürdal M, Bedi?r S.
  • Change in Frequency and Predictors of Erectile Dysfunction With Changes in the International Index of Erectile Function-Erectile Function Domain Score in Patients With ST-Elevation Myocardial Infarction: A Prospective, Longitudinal Study. J Sex Med. 2020 Jun;17(6):1101-1108. doi: 10.1016/j.jsxm.2020.03.002. Epub 2020 Mar 25. Karabay E, Karsiyakali N, Cinier G, Zeren G, Duvar S, Simsek B, Aslan AR, Karabay CY.
  • Predictive value of prognostic nutritional index on tumor stage in patients with primary bladder cancer. Arch Esp Urol. 2020;73(2):132-9. Karsiyakali N, Karabay E, Yucetas U.
  • Shock wave lithotripsy deteriorates male sexual functions related to the treatment-driven anxiety: A prospective, non-randomized, self-controlled study. Arch Esp Urol. 2020;73(9):826-36. Karsiyakali N, Erkan E, Yucetas U, Koseoglu H, Ates HA, Kadihasanoglu M, Toktas MG.
  • Re: "Total Surface Area Influences Stone Free Outcomes in Shock Wave Lithotripsy for Distal Ureteral Calculi" by Scotland et al. (J Endourol 2019;33 (8):661-666; DOI: 10.1089/end.2019.0120). J Endourol. 2020;34(5):640. J Endourol. 2020;34(5):640.
  • Intravesical Foreign Body Mimicking Bladder Tumour: A Rare Case Report. Endourol Bull 2020;12(1);31-34 Kaya E, Karsiyakali N, Sarikaya S, Akay S, Ebiloglu T, Zor M, Bedir S.
  • Assessment of Serum Creatinine, Cystatin C and Neutrophil Gelatinase-associated Lipocalin Levels in Rosacea: A Case-Control Study. Turkiye Klinikleri J Dermatol. 2020;30(2):49-55. https://doi.org/10.5336/dermato.2020-75109. Karabay EA, Karabay E, Demiral ÖU, Karşıyakalı N.
  • Evaluation of Nephrolithometric Scoring Systems to Predict Outcomes of Retrograde Intrarenal Surgery. Urol J. 2020;17(4):352-7. Karsiyakali N, Karabay E, Erkan E, Kadihasanoglu M.
  • Evaluation of Sleep Quality and Quantity of Patients with Benign Prostatic Hyperplasia Using the Medical Outcomes Study-sleep Scale. J Urol Surg. 2020;7(4):295-301. Sarıkaya S, Sarıkaya FG, Karşıyakalı N, Selvi İ, Şenocak Ç, Bozkurt ÖF, Esperto F, Vurucu M, Gürdal M
  • Neutrophil gelatinase-associated lipocalin is an early marker of renal damage in lower urinary tract obstruction in rats. Arch Esp Urol. 2020;73(6):554-60. Karabay E, Yucetas U, Aytac Ates H, Behzatoglu K, Yucetas E, Karsiyakali N, Kadihasanoglu M, Erkan E.
  • Analysis of urinary stone types? distribution in Turkey according to the geographical regions where patients were born and live: A cross-sectional single-center experience. Gulhane Med J 2020;62:163-169. DOI: 10.4274/gulhane.galenos.2020.978. Sarıkaya S, Yücel Ç, Karşıyakalı N, Sertoğlu E, Kaya E, Ebiloğlu T, Bedir S, Özgürtaş T.
  • Evaluation of relationship between visceral adiposity index and overactive bladder symptoms in females. Endoüroloji Bülteni. 2020; 12(2): 150-156. Karabay E, Karşıyakalı N, Kayar K, Veri?m L, Tosun Ç, Yücebaş Ö.
  • Hypospadias surgery on YouTube: is it valid? Minerva Pediatr 2019 Jul 25. https://doi.org/10.23736/S0026-4946.19.05555-5. Karabay E, Karsiyakali N, Kayar K, Koseoglu H.
  • Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study. BMC Urol. 2019 Sep 13;19(1):85. doi: 10.1186/s12894-019-0514-0. Karabay E, Karsiyakali N, Duvar S, Tosun C, Aslan AR, Yucebas OE.
  • Recurrent Urethral LGSIL Causing Macroscopic Hematuria. Sch J Med Case Rep, May, 2019; 7 (5): 348?350. https://doi.org/10.21276/sjmcr.2019.7.5.11. Karşıyakalı N, Köseoğlu H.
  • The Largest Cystic Nephroma Treated by Laparoscopic Nephron-sparing Surgery: A Case Report and Review of the Literature. J Urol Surg 2019;6:148-151. https://doi.org/10.4274/jus.galenos.2018.2190. Karşıyakalı N, Yücetaş U, Ateş HA, Baykal Koca S, Turan Bektaş C, Toktaş MG.
  • Open radical cystectomy is a reliable surgery with acceptable complication rates in elderly male patients: a retrospective, tertiary hospital-based study Aging Male. 2019:1-6. https://doi.org/10.1080/13685538.2019.1678127. Karabay E, Topaktas R, Tosun C, Karsiyakali N, Kayar K, Ozturk MI.
  • Testicular Malignant Mesothelioma. Ann Clin Case Rep. 2019; 4: 1729. Karsiyakali N, Koseoglu H, Yucetas U, Baykal Koca S, Aktaş S, Gokhan Toktas M.
  • Assessment of sleep characteristics of pediatric population with nocturnal enuresis: A tertiary hospital questionnaire based study. Gulhane Med J. 2019; 61(3): 114-117. http://dx.doi.org/10.26657/gulhane.00067. Sarıkaya S, Gökçem Yıldız F, Karşıyakalı N, Damar E, Şenocak Ç, Faruk Bozkurt Ö.
  • Re: Anatomic Basis and Clinical Effect of Selective Dorsal Neurectomy for Patients with Lifelong Premature Ejaculation: A Randomized Controlled Trial. J Sex Med. 2019;16(7):1122. https://doi.org/10.1016/j.jsxm.2019.05.002 Karsiyakali N, Sarikaya S, Karatas OF.
  • Retrograde Intrarenal Surgery or Shock Wave Lithotripsy?: Comparison of the Effects on Renal Functions by Glomerular Filtration Rate. J Urol Surg 2019;6:295-301. Doi: 10.4274/jus.galenos.2019.2967. Sarıkaya S, Karşıyakalı N, Sicimli C, Kaya E, Ebiloğlu T, Bedir S, Özgürtaş T, Karataş ÖF.
  • Testis Kanseri: Adjuvan Tedavilerde Erken ve Geç Dönem Yan Etkilerin Gözden Geçirilmesi. Ürolojik Onkoloji Bülteni, 2018; Cilt 2 - Sayı 2: 127-135 ISSN 2564-6699. Karşıyakalı N, Balaban M, Yücetaş U.
  • An Intrauterine Contraceptive Device that Migrated to the Bladder and Encrusted. IMJ 2017;18:103-105. https://doi.org/10.5152/imj.2017.80037. Çulha MG, Mansuroğlu B, Karşıyakalı N, Yücetaş U, Akay AF.

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP
How can we help you?